Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

  • There is currently no data for AUK

Trading Update

4 Nov 2019 07:00

RNS Number : 0483S
Aukett Swanke Group PLC
04 November 2019
 

 

Aukett Swanke Group plc

Trading Update and update regarding Aukett Swanke Moscow

Aukett Swanke Group Plc (the group) ("ASG"), the international group of architects, interior designers and associated engineering is pleased to provide the following trading update on performance to 30 September 2019.

The Board expressed the view that second half trading would be profitable and that this should result in recovering the first half loss to show a positive result at the year end. The Board is now pleased to be able to confirm that this remains the case and that the Group will achieve a profit for the full year to 30 September 2019, subject to there being no material impact for IFRS 9 and 15. Full year results will be reported in January 2020.

At the same time the Board can confirm that year end cash stood at £1,145,000 (2018: £710,000) and after deducting the Long Term Loan used to acquire Shankland Cox, Net Funds stood at £819,000 (2018: £157,000); a satisfactory improvement.

Trading in the new financial year has been stable though we remain vigilant regarding possible adverse impacts as a result the forthcoming General Election and prolonged Brexit negotiations.

Since the year end we have also sold the Group's subsidiary in Moscow, Aukett Swanke OOO ("AS Moscow"), having previously stated the Board's belief that AS Moscow would perform better under local ownership. Under the terms of a Sale Agreement AS Moscow was sold to Maxim Neretin, a Russian national, owner of Aurora Group (another Moscow based architectural practice) with whom the Group has previously co-operated on design projects, for a nominal consideration. The sale will result in inter-company loans being repaid to the Group and, under the terms of a licence arrangement, enables AS Moscow to continue to trade as Aukett Swanke, allowing the Group's brand to endure in this important market. The sale also safeguards our staffs' employment and was achieved without any warranties being provided to the new owner. AS Moscow made a loss of £17,000 in the year to 30 September 2018.

Commenting Nicholas Thompson, CEO, said:

"The recovery from the large loss in 2018 is a tribute to the perseverance of the staff in all of our operations and in the internal rigours of reducing cost during a difficult trading period.

The process to find a suitable successor to carry on the Russian business in our name has taken some considerable time to realise. Critically, the sale has safeguarded the interests of our staff in Moscow, avoids a costly closure process and provides some upside for shareholders through the ongoing licence arrangement. We are pleased with the outcome".

Enquiries

Aukett Swanke group Plc 020 7843 3000

Nicholas Thompson, Chief Executive Officer

Robert Fry, MD International

Tony Barkwith, Group Finance Director

 

finnCap 020 7220 0500

Corporate Finance: Julian Blunt/Giles Rolls

ECM: Alice lane

 

Investor /Media Enquiries 07979 604687

Chris Steele

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFSLFMFFUSELF
Date   Source Headline
25th Sep 20189:14 amRNSChange of Registered Office
25th Sep 20187:00 amRNSBoard Changes
5th Jul 20184:40 pmRNSSecond Price Monitoring Extn
5th Jul 20184:35 pmRNSPrice Monitoring Extension
5th Jul 20182:05 pmRNSSecond Price Monitoring Extn
5th Jul 20182:00 pmRNSPrice Monitoring Extension
28th Jun 20187:00 amRNSInterim results
13th Jun 20184:40 pmRNSSecond Price Monitoring Extn
13th Jun 20184:35 pmRNSPrice Monitoring Extension
29th Mar 201810:36 amRNSResult of AGM
29th Mar 20187:00 amRNSDirectorate Change and Trading Update
28th Feb 201810:39 amRNSPosting of AGM Notice and Report and Accounts
23rd Jan 20182:46 pmRNSDirector/PDMR Shareholding
15th Jan 20185:23 pmRNSDirector/PDMR Shareholding
12th Jan 20184:28 pmRNSDirector/PDMR Shareholding
11th Jan 20187:00 amRNSFinal Results
20th Dec 20171:58 pmRNSWorld Architecture 100
14th Nov 20177:00 amRNSContract
8th Nov 20177:00 amRNSIndustry Award Wins
6th Sep 20177:00 amRNSAdelphi Fully Let
14th Aug 20177:00 amRNSAppointment of UK Studio Director
10th Aug 20177:00 amRNSMajor Industry Award
20th Jun 20177:00 amRNSInterim Results
11th May 20174:14 pmRNSTrading Update
26th Apr 20177:00 amRNSDirector/PDMR Shareholding
30th Mar 20171:53 pmRNSResult of AGM
6th Mar 20172:37 pmRNSDirector/PDMR Shareholding
12th Jan 20177:00 amRNSFinal Results
9th Jan 201710:05 amRNSNotice of Results
8th Aug 20167:40 amRNSAukett Swanke News
19th Jul 20169:27 amRNSHolding(s) in Company
30th Jun 201612:30 pmRNSDirector/PDMR Shareholding
29th Jun 201610:10 amRNSCopy of Magazine article
28th Jun 20165:20 pmRNSDirector/PDMR Shareholding
24th Jun 20161:55 pmRNSDirector / PDMR Shareholding
7th Jun 20167:00 amRNSInterim Results
18th May 20167:00 amRNSMajor Berlin Regeneration Project
14th Apr 20167:00 amRNSGreen Park Reading masterplan
4th Apr 20163:00 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20164:34 pmRNSDirector/PDMR Shareholding
30th Mar 201610:32 amRNSResult of Annual General Meeting
22nd Mar 20167:00 amRNSBelmont Works Birmingham update
22nd Feb 20167:00 amRNSRegional work expands:Cambridge's new start-up hub
11th Feb 20167:00 amRNSAcquisition of Shankland Cox Limited
28th Jan 20167:00 amRNSFinal Results
22nd Dec 20157:00 amRNSDirectorate Change
3rd Dec 20157:00 amRNSNotice of Results
9th Sep 20158:04 amRNSHolding(s) in Company
8th Sep 20157:00 amRNSDirector Shareholdings
31st Jul 20152:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.